Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that reduce costs and accelerate production.
In a report released yesterday, Luca Issi from RBC Capital maintained a Hold rating on Sangamo Biosciences (SGMO – Research Report), with a ...
RBC Capital analyst Luca Issi reiterated a Buy rating on Korro Bio (KRRO – Research Report) yesterday and set a price target of $95.00. The ...
The Motley Fool on MSN5d
Down 93%, Is It Finally Time to Buy Moderna?Moderna's shockingly low valuation and robust pipeline are attractive features. An enterprise value of around $6 billion puts ...
The pharmaceutical company said, “The allegations that came out in the media are entirely baseless, distorted, and part of a smear campaign" ...
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies ...
3d
News-Medical.Net on MSNScientists say NIH officials told them to scrub mRNA references on grantsNational Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...
Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...
GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents ...
Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments. The facility is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results